![conference banner](/images/conference-banner.jpeg)
Abstract
Abnormalities of coagulation have been reported in patients with thyroid dysfunction, although there is no clear information to explain the mechanism behind such irregularities. We are presenting a case of subclinical hypothyroidism that came with coagulation disturbance (hypocoagulation). Her symptoms resolved with leothyroxin in 4 weeks. Further studies are needed to clear the pathogenesis of the coagulation disturbance in such setting. The article also outlines some patents on hypothyroidism and hyperthyroidism.
Keywords: Hemostasis, hypercoagulability hypocoagulability, subclinical thyroid dysfunction, thyroid dysfunction, hypothyroidism, Graves’ disease, vitamin-mineral complexes, levothyroxine, Willebrand factor
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Volume: 6 Issue: 2
Author(s): Parvaneh Ehsanzadeh-Cheemeh, Michelle Thompson and Michal Miller
Affiliation:
Keywords: Hemostasis, hypercoagulability hypocoagulability, subclinical thyroid dysfunction, thyroid dysfunction, hypothyroidism, Graves’ disease, vitamin-mineral complexes, levothyroxine, Willebrand factor
Abstract: Abnormalities of coagulation have been reported in patients with thyroid dysfunction, although there is no clear information to explain the mechanism behind such irregularities. We are presenting a case of subclinical hypothyroidism that came with coagulation disturbance (hypocoagulation). Her symptoms resolved with leothyroxin in 4 weeks. Further studies are needed to clear the pathogenesis of the coagulation disturbance in such setting. The article also outlines some patents on hypothyroidism and hyperthyroidism.
Export Options
About this article
Cite this article as:
Ehsanzadeh-Cheemeh Parvaneh, Thompson Michelle and Miller Michal, Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2012; 6 (2) . https://dx.doi.org/10.2174/187221412800604590
DOI https://dx.doi.org/10.2174/187221412800604590 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Advances in the Synthesis and Bioactivity of Polysaccharide Selenium
Nanoparticles: A Review
Mini-Reviews in Medicinal Chemistry Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?
Current Cancer Drug Targets Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Mini-Reviews in Medicinal Chemistry Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Anti-Cancer Agents in Medicinal Chemistry Induction of CYP1A1. The AhR / DRE Paradigm Transcription, Receptor Regulation, and Expanding Biological Roles
Current Drug Metabolism Unequivocal Role of Pyrazine Ring in Medicinally Important Compounds: A Review
Mini-Reviews in Medicinal Chemistry Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond
Current Aging Science Beyond the Reproductive Effect of Sex Steroids: Their Role During Immunity to Helminth Parasite Infections
Mini-Reviews in Medicinal Chemistry Malnutrition: A Longstanding Challenge in India
Current Nutrition & Food Science PET Tracers Based on Zirconium-89
Current Radiopharmaceuticals Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?
Current Drug Targets Mitochondria and Familial Predisposition to Breast Cancer
Current Genomics Update on the Biological Relevance of Lysine Acetylation as a Novel Drug Target in Trypanosomatids
Current Medicinal Chemistry Ghrelin in Obesity, Physiological and Pharmacological Considerations
Mini-Reviews in Medicinal Chemistry Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
Current Drug Targets Regulatory T Cells and Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) The Regulation of Selenoproteins in Diabetes: A New Way to Treat Diabetes
Current Pharmaceutical Design Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer
Current Medicinal Chemistry